DHA is essential for the cognitive health and brain function in growing children. When it comes to a liquid form of DHA, every kid would vote for Nordic Naturals Children’s DHA liquid as their No. 1 choice. It is made from arctic cod liver oil and provides excellent source of optimum omega 3 fatty acids and healthy levels of 100% natural vitamin A and D in a delicious strawberry flavor. Nordic Naturals Children’s DHA is delivered within hours of being caught to the plant for molecular processing in a nitrogen environment, resulting in the purest and best-tasting cod liver oil.

What Are the Key Health Benefits Associated with Nordic Naturals Children’s DHA Liquid?

• Support cognitive health and brain function
• Improves attention deficit hyperactivity disorder, autism and aggressive behaviors
• Helps in the development of healthy eyes, nerves and skin in growing children
• Maintains healthy cardiovascular system
• Provides visual support

Each ½ Teaspoon Contains: Cod Liver Oil (from arctic cod)|2500mg Docosahexaenoic Acid (DHA)|245mg Eicosapentaenoic Acid (EPA)|175mg Other Omega-3 Fatty Acids|105mg Vitamin D|0-0.25mcg Non-Medicinal Ingredients: natural strawberry flavour, vitamin E, rosemary extract.

Children: Children aged 3 to 18 years - Take ½ teaspoon daily, with food, or as directed by your health care practitioner. Caution: Tamper-proof seal; do not use this product if safety seal is broken or missing. Store in an airtight container, protected from light. Refrigerate after opening.

Sorgi, Paul J., et al. "Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder." Nutr J 6.16 (2007): 16. Voigt, Robert G., et al. "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder." The Journal of pediatrics 139.2 (2001): 189-196. Amminger, G. Paul, et al. "Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study."Biological psychiatry 61.4 (2007): 551-553.